New meeting on Precision Oncology 2019
A personalized approach in oncology takes gradually over from guidelines and relies on molecular biology of cancer cells. The information comes largely from tissue research. Therefore we, ECP and spin-off companies, concentrated on high quality tissues coming from patients (treatment related) or individuals (prevention) in the most comfortable and safe way. But there is another factor, advances in molecular biology […]